Skip to main content
Journal of General Internal Medicine logoLink to Journal of General Internal Medicine
. 2019 Jan 8;34(3):479–480. doi: 10.1007/s11606-018-4816-9

Chickenpox in a Vaccinated Adult

Lisa Chu 1,, Sally Daganzo 2, Paul Aronowitz 1
PMCID: PMC6420673  PMID: 30623385

A healthy 37-year-old man presented with a pruritic rash, chills, and body aches for three days. He was afebrile and had scattered vesicles on an erythematous base, on his trunk and extremities (Figs. 1 and 2). He reported never having chickenpox but had received two doses of the varicella vaccine at age 20. He worked at a nursing home where a resident had recently developed shingles. Vesicular fluid PCR testing was positive for varicella zoster, consistent with chickenpox.

Fig. 1.

Fig. 1

Vesicular rash on trunk.

Fig. 2.

Fig. 2

Vesicular rash on back.

The varicella zoster virus (HHV-3) can cause two forms of disease—primary infection (varicella, or chickenpox) and a reactivation disorder (herpes zoster). This patient developed chickenpox almost two decades after being vaccinated. Each year after vaccination, the rate of breakthrough varicella increases.1 A meta-analysis found approximately 80% effectiveness for a single dose in preventing varicella disease of any severity and over 99% effectiveness in preventing severe disease (defined by > 500 lesions, complications requiring medical care, hospitalization, or death). Two doses increased the mean effectiveness to approximately 92 to 93% in preventing breakthrough varicella of any severity.2, 3 This patient was treated with a 7-day course of valacyclovir and was advised to stay home from work for two weeks.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Chavez SS, Gargiullo P, Zhang JX, et al. Loss of Vaccine-Induced Immunity to Varicella over Time. N Engl J Med. 2007;356:1121–1129. doi: 10.1056/NEJMoa064040. [DOI] [PubMed] [Google Scholar]
  • 2.Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global Varicella Vaccine Effectiveness: A Meta-analysis. Pediatrics. 2016;137(3):e20153741. doi: 10.1542/peds.2015-3741. [DOI] [PubMed] [Google Scholar]
  • 3.Zhu S, Zeng F, Xia L, He H, Zhang J. Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis. Am J Infect Control. 2018;46(1):e1–7. doi: 10.1016/j.ajic.2017.07.029. [DOI] [PubMed] [Google Scholar]

Articles from Journal of General Internal Medicine are provided here courtesy of Society of General Internal Medicine

RESOURCES